Straumann Holding AG (OTCMKTS:SAUHY) Sees Significant Growth in Short Interest

Key Points

• Short interest surged to 36,373 shares as of April 15, a rise of 9,226.4% from 390 shares on March 31, with a days-to-cover ratio of 0.1 days based on average daily volume.
• Analyst sentiment is weak—Straumann's consensus rating is "Reduce" (1 Buy, 2 Hold, 2 Sell), with Morgan Stanley reiterating an underweight and Citigroup a sell.
• Shares traded at $10.81 on the most recent session with volume below average (67,593 vs. 205,411), a 52-week range of $9.44–$14.18, and 50-/200-day SMAs near $10.98 and $11.57 respectively.

Straumann Holding AG (OTCMKTS:SAUHY - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 36,373 shares, a growth of 9,226.4% from the March 31st total of 390 shares. Based on an average daily volume of 325,187 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold.

Analysts Set New Price Targets

SAUHY has been the topic of several research analyst reports. Morgan Stanley restated an "underweight" rating on shares of Straumann in a research note on Tuesday, April 14th. Citigroup reaffirmed a "sell" rating on shares of Straumann in a research report on Thursday. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Straumann currently has an average rating of "Reduce".

Straumann Price Performance

OTCMKTS SAUHY traded up $0.09 during trading hours on Friday, hitting $10.81. The company had a trading volume of 67,593 shares, compared to its average volume of 205,411. Straumann has a fifty-two week low of $9.44 and a fifty-two week high of $14.18. The business has a fifty day simple moving average of $10.98 and a 200-day simple moving average of $11.57.

Straumann Company Profile

Straumann OTCMKTS: SAUHY is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company's core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.